Search clinical trials for: Rotigotine

Total 105 results

University Hospital, Rouen

Not yet recruiting

Safety of RotigotiNe in Patients With Autosomal Dominant Polycystic Kidney Disease (ETERNAL-PKD)

Kidney Diseases
Virginia Commonwealth University
National Institute on Drug Abuse (NIDA)

Recruiting

Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder

Substance-Related Disorders

United States
Peking University Third Hospital

Recruiting

The Practical Effect of Neupro

Parkinson's Disease

China
MDD US Operations, LLC a subsidiary of Supernus...

Active, not recruiting

Infusion of Apomorphine: Long-term Safety Study (INFUS-ON)

Idiopathic Parkinson's Disease

United States
SocraTec R&D GmbH
Luye Pharma Group Ltd.; SocraMetrics GmbH

Completed

Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease

Patch Adhesion | Local Tolerability

Germany
UCB Biopharma SRL

Terminated

A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome

Restless Legs Syndrome

United States
UCB Biopharma SRL

Terminated

A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause

Restless Legs Syndrome

United States
Massachusetts General Hospital

Withdrawn

Butrans for Treatment of Restless Legs Syndrome (Butrans)

Restless Legs Syndrome

United States
Luye Pharma Group Ltd.
Parexel

Completed

A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PD

Parkinson Disease

China
Serina Therapeutics

Active, not recruiting

A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214

Parkinson's Disease

United States
I.R.C.C.S. Fondazione Santa Lucia
Alzheimer's Drug Discovery Foundation

Active, not recruiting

Dopaminergic Therapy for Frontotemporal Dementia Patients

Mental Disorders | Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Neurologic Manifestations | Neurobehavioral Manifestations | Neurocognitive Disorders | Neurodegenerative Diseases | TDP-43 Proteinopathies | Proteostasis Deficiencies | Dementia | Language Disorders | Communication... and other conditions

Italy
Luye Pharma Group Ltd.

Completed

A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro

Parkinson Disease

United States
Sandoz

Terminated

An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Transdermal Patches Containing Rotigotine.

Parkinson Disease

Germany
Luye Pharma Group Ltd.

Completed

A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy Volunteers

Parkinson Disease

United States
Luye Pharma Group Ltd.
Beijing Bozhiyin T&S Co., Ltd.

Completed

A Multiple Ascending Dose Study With LY03003 in Patients With Early-stage Parkinson's Disease

Parkinson Disease

China
Peking University Third Hospital

Completed

Efficacy and Safety of Rotigotine in the Treatment of Patients With Early Stage of Primary Parkinson's Disease

Parkinson's Disease

China
Johns Hopkins University
National Institute on Aging (NIA)

Terminated

Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment (ANXPD)

Parkinson Disease | Anxiety Disorders

United States
Luye Pharma Group Ltd.
Beijing Bozhiyin T&S Co., Ltd.

Completed

A Study of LY03003 in Patients With Early-stage Parkinson's Disease

Parkinson Disease
UCB Biopharma S.P.R.L.

Completed

Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms Management

Parkinson´s Disease

United States
I.R.C.C.S. Fondazione Santa Lucia

Completed

Effects of Dopaminergic Therapy in Patients With Alzheimer's Disease (DOPAD)

Alzheimer Disease

Italy
Luye Pharma Group Ltd.

Completed

Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease

Parkinson Disease

United States
UCB BIOSCIENCES GmbH

Completed

Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy (BRIGHT)

Idiopathic Parkinson's Disease

United States, Austria, Hungary, Poland, Slovakia, Slovenia, Spain
Janssen Research & Development, LLC

Completed

A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease

Cardiovascular Diseases | Diabetes Mellitus, Type 2

United States
UCB Pharma

Completed

Transdermal Rotigotine User Surveillance Study (TRUST)

Idiopathic Parkinson Disease

Czechia, Denmark, Germany, Greece, Italy, Mexico, Romania, Slovakia, Spain, Switzerland
Gretchen Wells

Terminated

Estrogen Diastolic Heart Failure

Menopause

United States
University Hospital, Montpellier

Completed

Effect of Rotigotine Patch Treatment on Cardiovascular Markers in Idiopathic Restless Legs Syndrome

Restless Legs Syndrome (RLS)

France
GlaxoSmithKline

Completed

A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects

Diabetes Mellitus, Type 2

United States
UCB Pharma GmbH

Completed

Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease (NEUPAD)

Idiopathic Parkinson's Disease

Germany, Austria
UCB Pharma
UCB Trading (Shanghai) Co. Ltd.

Completed

Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients

Idiopathic Parkinson's Disease

China
UCB Pharma

Completed

Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation (AURORA)

Restless Legs Syndrome

Germany
UCB BIOSCIENCES, Inc.

Completed

Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome

Restless Legs Syndrome

United States
University Hospital, Grenoble

Unknown

Non Motors Aspects in De Novo Parkinson's Disease (Honeymoon)

Parkinson Disease | Apathy

France
UCB BIOSCIENCES, Inc.

Completed

Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome

Restless Legs Syndrome

United States
Chulalongkorn University
Abbott

Unknown

Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quantitative Assessment by Wearable Sensors

Nocturnal Hypokinesia
Luye Pharma Group Ltd.

Completed

Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease

Parkinson's Disease

United States
John Winkelman, MD, PhD
UCB Pharma

Completed

Switching From Oral Dopamine Agonists to Rotigotine (SWITCH)

Restless Legs Syndrome | Ekbom Syndrome | Willis-Ekbom Disease

United States
Sleep Medicine Centre Kempenhaeghe

Terminated

Measuring the Effects of Continuous Dopaminergic Stimulation on Nocturnal Movements in Parkinson's Disease

Nocturnal Hypokinesia | Parkinsons's Disease | Rotigotine

Netherlands
UCB Biopharma S.P.R.L.
PRA Health Sciences

Completed

Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease (NEUPART)

Idiopathic Parkinson's Disease

Germany, France, Italy, Spain, United Kingdom
Inflamax Research Incorporated

Completed

Irritation and Sensitization Potential of Repeat Applications of Rotigotine Patch

Bioequivalence - Irritation and Sensitization Potential of Transdermal Patch

United States, Canada
Azienda Ospedaliera Cardinale G. Panico

Terminated

Possible Use of Rotigotine in Subjects 70 Years and Older With Late Onset of Disease (PARROT)

Parkinson's Disease

Italy
UCB Korea Co., Ltd.

Completed

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Idiopathic Parkinson's Disease

Korea, Republic of
UCB BIOSCIENCES GmbH
Pharmaceutical Health Sciences; Bracket Global

Completed

A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease

Parkinson's Disease

Germany
Luye Pharma Group Ltd.

Completed

Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease (03003MAD)

Parkinson's Disease

United States
UCB Pharma

Completed

Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients

IDIOPATHIC PARKINSON'S DISEASE

China
East Carolina University

Unknown

Study to Assess Dopamine Receptor Modulation With Rotigotine to Enhance Morphine Analgesia in the Dental Model

Post-op Pain

United States
UCB Pharma

Completed

The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults. (SP888)

Fibromyalgia Syndrome

United States
UCB Pharma

Completed

Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine (RECOVER)

Parkinson's Disease

United States, Poland, United Kingdom, Spain, South Africa, Austria, Germany, Hungary, Italy, New Zealand, Australia, Finland
UCB BIOSCIENCES GmbH

Completed

Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain (DOLORES)

Advanced Idiopathic Parkinson's Disease

United States, Germany, Poland, Slovakia
UCB BIOSCIENCES GmbH

Completed

A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis

Restless Legs Syndrome | End-Stage Renal Disease

United States, Austria, Finland, France, Germany, Italy
UCB Pharma

Completed

Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch

Parkinson's Disease

United States, Chile, Mexico, India, Peru

3

Subscribe